Cerebral symptomatic toxoplasmosis treated by sulfadoxine/pyrimethamine treatment. About 6 patients;Toxoplasmose cérébrale symptomatique traitée par sulfadoxine/pyriméthamine chez 6 patients

Therapie

Volumn 63, Issue 1, 2008, Pages 71-72

  Iba Ba, Josaphat ^a   Ibouili, Rufin Bignoumba ^a   Kombila, Jean Baptiste Moussavou ^a   Nzenze, Jean Raymond ^b   Drave, Madani ^c   Essola, Laurence ^c   Ivala, Mathieu ^c   Mistoul, Irène ^d   Kerault, Lydie ^e   Menye, Blaise ^f   Boguikouma, Jean Baptiste ^a  

^a Service de Médecine Interne A   (Gabon)

^b Hôpital des Instructions des Armées OBO   (Gabon)

^c Service d'Oxyologie   (Gabon)

^d Service d'Infectiologie   (Gabon)

^e Service de Radiologie   (Gabon)

^f CENTRE HOSPITALIER DE LIBREVILLE   (Gabon)

Author keywords

Pyrimethamine; Sulfadoxine; Toxoplasmosis

Indexed keywords

PYRIMETHAMINE; SULFADOXINE; ANTIINFECTIVE AGENT;

ADULT; ARTICLE; BRAIN INFECTION; CLINICAL ARTICLE; CLINICAL PROTOCOL; DRUG EFFICACY; FEMALE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LENGTH OF STAY; MALE; PRIORITY JOURNAL; TOXOPLASMA GONDII; TOXOPLASMOSIS; TREATMENT OUTCOME; DRUG COMBINATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; NUCLEAR MAGNETIC RESONANCE IMAGING;

ADULT; ANTI-INFECTIVE AGENTS; DRUG COMBINATIONS; FEMALE; HIV SEROPOSITIVITY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PYRIMETHAMINE; SULFADOXINE; TOXOPLASMOSIS, CEREBRAL;

EID: 46649119958     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: 10.2515/therapie:2008011     Document Type: Article

References (6)

1. Schurmann D, Bergmann F, Albrecht H, et al. Effectiveness of twice-weekly. Pyrimethamine-sulfadoxine as primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis in patients with advanced HIV infection. Eur J Clin Microbiol Infect Dis 2002; 21(5): 353-61
2. Schurmann D, Bergmann F, Albrecht H, et al. Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS. J Infect 2001; 42(1): 8-15
3. Ruf B, Schurmann D, Bergmann F, et al. Encephalitis relapses and Pneumocystis carinii pneumonia in HIV-infected patients. Eur J Clin Microbiol Infect Dis 1993; 12(5): 325-9
4. Koppen S, Grunewald T, Jautzke G, et al. Prevention of pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus infected patients: a clinical approach comparing aerosolized pentamidine and pyrimethamine/sulfadoxine. Clin Investig 1992; 70(6): 508-12
5. Teira R, Virosta M, Baraia-Etxaburu J, et al. Pyrimethamine and sulfadoxine as a preventive treatment for Pneumocystis carinii and toxoplasma encephalitis. Enferm Infecc Microbiol Clin 1999; 17(7): 347-9
6. Ruf B, Schürmann D, Bergmann F, et al. Efficacy of pyrimethamine/sulfadoxine in the prevention of toxoplasmic encephalitis relapses and Pneumocystis carinii pneumonia in HIV-infected patients. Eur J Clin Microbiol Infect Dis 1993; 12(5): 325-9